BOOST Pharma
February 10, 2025
Gene/Cell Therapy
BOOST Pharma is a clinical-stage biopharmaceutical company focused on the development of novel cell therapy treatments. The company is currently developing a first-in-class therapy to treat Osteogenesis Imperfecta (OI), a serious, inherited rare genetic disease leading to severe physical disability.
)
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}